๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Camptothecin and taxol: Discovery to clinic

โœ Scribed by Monroe E. Wall


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
193 KB
Volume
18
Category
Article
ISSN
0198-6325

No coin nor oath required. For personal study only.

โœฆ Synopsis


Camptothecin (CPT) is a pentacyclic alkaloid isolated from wood and bark of Camptotheca acuminata. Initially it was found to be highly active in a number of mouse in vivo cancer assays. Subsequently, CPT was found to uniquely inhibit an enzyme, topoisomerase I, which is involved in DNA replication. A number of CPT analogs are in advanced clinical trial, and two, Topotecan and CPT-11, have been approved for marketing by the FDA. taxol, a taxane alkaloid, was isolated from Taxus brevifolia. Taxol is a highly cytotoxic compound active in several mouse antitumor assays. It was subsequently found to uniquely inhibit tubulin, a protein involved in mitosis. After clinical evaluation, it has become the drug of choice for treatment of ovarian cancer.


๐Ÿ“œ SIMILAR VOLUMES


Paclitaxel (Taxolยฎ): A success story wit
โœ Gordon M. Cragg ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 204 KB

The discovery and development of paclitaxel, which covered a time span of some 30 years, has provided some important lessons for those involved in natural product drug discovery and development. These include the adoption of novel screens as they become available, the elucidation of mechanisms of ac